阻滞剂-话题@MedSci

#阻滞剂#

205篇内容 | 4061人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085841, encodeId=dede2085841e4, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=NEJM：肾素-血管紧张素系统阻滞剂与Covid-19风险, objectType=article, longId=196082, objectId=ae831960822f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae831960822f, replyNumber=0, likeNumber=101, createdTime=2021-01-29, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae831960822f, moduleTitle=NEJM：肾素-血管紧张素系统阻滞剂与Covid-19风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae831960822f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085837, encodeId=fdef208583eec, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件, objectType=article, longId=190425, objectId=b42d19042540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b42d19042540, replyNumber=0, likeNumber=49, createdTime=2020-06-28, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b42d19042540, moduleTitle=Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b42d19042540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085839, encodeId=60a8208583937, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析, objectType=article, longId=190793, objectId=9b03190e930f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b03190e930f, replyNumber=0, likeNumber=64, createdTime=2020-10-17, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b03190e930f, moduleTitle=Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b03190e930f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085840, encodeId=5edb208584013, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局, objectType=article, longId=196010, objectId=c6ff19601043, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ff19601043, replyNumber=0, likeNumber=68, createdTime=2021-03-19, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ff19601043, moduleTitle=Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ff19601043)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085831, encodeId=bb40208583157, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, objectType=article, longId=186120, objectId=462318612022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318612022, replyNumber=0, likeNumber=60, createdTime=2020-12-23, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318612022, moduleTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318612022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085825, encodeId=6cc22085825c9, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活, objectType=article, longId=178695, objectId=31bd1e8695c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31bd1e8695c9, replyNumber=0, likeNumber=58, createdTime=2020-07-04, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31bd1e8695c9, moduleTitle=第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31bd1e8695c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085821, encodeId=0cd92085821f2, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好, objectType=article, longId=167270, objectId=9fef16e27098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fef16e27098, replyNumber=0, likeNumber=81, createdTime=2020-03-14, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fef16e27098, moduleTitle=J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fef16e27098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085824, encodeId=6b902085824d1, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β受体阻滞剂治疗高血压的临床应用建议, objectType=article, longId=177194, objectId=81581e7194c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81581e7194c3, replyNumber=0, likeNumber=35, createdTime=2020-03-25, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81581e7194c3, moduleTitle=β受体阻滞剂治疗高血压的临床应用建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81581e7194c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085830, encodeId=c2f72085830b3, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险, objectType=article, longId=184381, objectId=81dd184381f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81dd184381f4, replyNumber=0, likeNumber=78, createdTime=2019-12-13, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81dd184381f4, moduleTitle=JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81dd184381f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085827, encodeId=17f0208582e77, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联, objectType=article, longId=179821, objectId=27381e98217d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27381e98217d, replyNumber=0, likeNumber=54, createdTime=2020-03-21, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27381e98217d, moduleTitle=Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27381e98217d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085832, encodeId=9398208583207, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, objectType=article, longId=186169, objectId=d65f1861694f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d65f1861694f, replyNumber=0, likeNumber=0, createdTime=2020-08-11, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d65f1861694f, moduleTitle=中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d65f1861694f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085829, encodeId=3cbf2085829f5, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Clinica Chimica Acta：循环生长分化因子-15、kruppel样因子4和生长阻滞剂特异性6与冠心病的关系, objectType=article, longId=181508, objectId=01041815088d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01041815088d, replyNumber=0, likeNumber=72, createdTime=2020-07-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01041815088d, moduleTitle=Clinica Chimica Acta：循环生长分化因子-15、kruppel样因子4和生长阻滞剂特异性6与冠心病的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01041815088d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085828, encodeId=b44a208582838, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据, objectType=article, longId=181083, objectId=db6b181083ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db6b181083ec, replyNumber=0, likeNumber=60, createdTime=2020-04-06, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db6b181083ec, moduleTitle=冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db6b181083ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085818, encodeId=7120208581850, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=β受体阻滞剂在高血压应用中的专家共识, objectType=article, longId=165739, objectId=3a78165e3980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a78165e3980, replyNumber=0, likeNumber=0, createdTime=2019-06-30, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a78165e3980, moduleTitle=β受体阻滞剂在高血压应用中的专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a78165e3980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085816, encodeId=e415208581657, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, objectType=article, longId=162908, objectId=a3c81629085d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c81629085d, replyNumber=0, likeNumber=59, createdTime=2020-01-05, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c81629085d, moduleTitle=2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c81629085d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085815, encodeId=647e20858158a, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, objectType=article, longId=160232, objectId=cfc5160232ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc5160232ec, replyNumber=0, likeNumber=53, createdTime=2019-07-03, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc5160232ec, moduleTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc5160232ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085820, encodeId=a358208582074, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, objectType=article, longId=166800, objectId=cf8f166800fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8f166800fa, replyNumber=0, likeNumber=117, createdTime=2020-02-09, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8f166800fa, moduleTitle=2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf8f166800fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085823, encodeId=1d432085823af, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险, objectType=article, longId=176009, objectId=eefe1e6009d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eefe1e6009d3, replyNumber=0, likeNumber=52, createdTime=2019-09-25, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefe1e6009d3, moduleTitle=Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eefe1e6009d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085813, encodeId=a5ec208581329, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Eur Arch Otorhinolaryngol：过敏原阻滞剂机械阻隔凝胶对过敏性鼻炎患者症状和生活质量效果评估, objectType=article, longId=156902, objectId=c60a156902bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60a156902bb, replyNumber=0, likeNumber=56, createdTime=2019-11-07, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60a156902bb, moduleTitle=Eur Arch Otorhinolaryngol：过敏原阻滞剂机械阻隔凝胶对过敏性鼻炎患者症状和生活质量效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60a156902bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085808, encodeId=5eb22085808ea, content=<a href='/topic/show?id=723a9e69383' target=_blank style='color:#2F92EE;'>#阻滞剂#</a>, objectTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, objectType=article, longId=151179, objectId=10aa1511e908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10aa1511e908, replyNumber=0, likeNumber=62, createdTime=2019-07-25, rootId=0, userName=zhyy88, userId=40be178, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10aa1511e908, moduleTitle=Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10aa1511e908)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻滞剂

2020-05-29

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

NEJM：肾素-血管紧张素系统阻滞剂与Covid-19风险

2021-01-29

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件

2020-06-28

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Am Heart J：出院时β阻滞剂处方不足70%！中国近三万非ST段抬高型急性冠脉综合征分析

2020-10-17

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局

2021-03-19

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%

2020-12-23

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活

2020-07-04

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

J Geriatr Cardiol:阜外医院周宪梁团队发现，β阻滞剂降白天血压有优势，利尿剂控制夜间血压好

2020-03-14

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β受体阻滞剂治疗高血压的临床应用建议

2020-03-25

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险

2019-12-13

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联

2020-03-21

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%

2020-08-11

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Clinica Chimica Acta：循环生长分化因子-15、kruppel样因子4和生长阻滞剂特异性6与冠心病的关系

2020-07-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

冠心病应用β阻滞剂严重不规范！报告67家医院1.3万例冠心病患者数据

2020-04-06

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

β受体阻滞剂在高血压应用中的专家共识

2019-06-30

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

2019版《β受体阻滞剂在高血压应用中的专家共识》在京发布

2020-01-05

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率

2019-07-03

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

2019年美国胸科协会年会：β受体阻滞剂可降低肺移植后房颤的发生率

2020-02-09

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险

2019-09-25

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Eur Arch Otorhinolaryngol：过敏原阻滞剂机械阻隔凝胶对过敏性鼻炎患者症状和生活质量效果评估

2019-11-07

zhyy88 (审核中...)

前往app查看评论内容

#阻滞剂#

Ann Intern Med：β受体阻滞剂在孕妇中的使用情况和先天性畸形的风险

2019-07-25

科室
- - 订阅+
  - 更多科室
工具
服务